Posted by Michael Wonder on 20 Nov 2016
TGA approves Grifols' Prolastin C
17 November 2016 - The TGA has approved Grifols' new alfa-1-proteinase inhibitor.
Prolastin C was approved by the TGA on 10 November 2016 to increase serum alfa1-PI levels in adults with congenital deficiency of alfa-1 antitrypsin and with clinically significant emphysema (FEV1 <80%).
